Steven C. Eror

Chief Executive Officer, President, Director


JeffREY S. O’Driscoll, MD

Chief Medical Officer

Michael A. Garff

Chief Operating Officer


Company Mission

Our mission is to improve outcomes for potential lung cancer patients through early predictive technologies, provide cost savings to patients, payers, and providers, and to provide a fair return on investment to shareholders and other stakeholders.

ProLung is committed to making a positive and significant impact on the healthcare community and to being socially responsible in all its endeavors.


Board of Directors


Todd P. Morgan
Chairman of the Board of Directors

Steven C. Eror
CEO, President, Director


Robin L. Smith, MD, MBA

Robert W. Raybould

John C. Ruckdeschel, MD

Clark A. Campbell

Richard B. McKeown

J. Scott Nixon, CPA


Associates & Staff

Kristin Larson, NP
Manager of Clinical Research & Training

Lindsay McSweeney
Executive Assistant

Caroline Rigby
Administrative Assistant

Marcie Skinner


Tyson Sperry
Senior Accountant

Mariana Medina
Senior Accountant

Cory Kelley
Manufacturing Manager

Ryan Snow
Director of Business Development

Maveric Searle
Manager of Database & Analytics

Chris Grayston
IT Testing Engineer

Vincent Fu
Marketing & Brand Development